SCHEMBL4883401

SCHEMBL4883401

CCOC(=O)C(Cc1ccc(OCCCl)cc1)OCC

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 19/20 0.56
PPARG P37231 14/20 0.55
PPARD Q03181 8/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5892164 0.91 PPARA (0.54) PPARAPPARGPPARD
SCHEMBL4258664 0.88 PPARA (0.52) PPARAPPARGPPARD
SCHEMBL4758451 0.88 PPARA (0.57) PPARAPPARGPPARD
SCHEMBL4758419 0.88 PPARA (0.57) PPARAPPARGPPARD
SCHEMBL4653947 0.88 PPARA (0.72) PPARAPPARGPPARD
SCHEMBL4755574 0.88 PPARA (0.57) PPARAPPARGPPARD
SCHEMBL11932217 0.86 PPARA (0.56) PPARAPPARGPPARD
SCHEMBL6387457 0.86 PPARA (0.56) PPARAPPARGPPARD
SCHEMBL5978209 0.86 PPARA (0.56) PPARAPPARGPPARD
SCHEMBL4790094 0.86 PPARA (0.58) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113974-A1 Heterocyclic Oxime Compounds, A Process For Their Preparation And Pharmaceutical Compositions Containing Them. LES LABORATOIRES SERVIER (FR) 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113974-A1 Heterocyclic Oxime Compounds, A Process For Their Preparation And Pharmaceutical Compositions Containing Them. CBR1, CYP3A7, CYP2C9 PPARA 1634/4885PPARG 1185/4885PPARD 1308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.